Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Alterations in p53 predict response to preoperative high dose chemotherapy in patients with gastric cancer.

Molecular pathology : MP - 1 Oct 2003

Bataille F, Rümmele P, Dietmaier W, Gaag D, Klebl F, Reichle A, Wild P, Hofstädter F, Hartmann A

Abstract excerpt

AIMS: To evaluate the usefulness of molecular markers in predicting histopathological and clinical response to preoperative high dose chemotherapy (HDCT) and survival of patients with advanced gastric cancer. METHODS: In a phase II trial, 25 patients with metastatic gastric cancer received preoperative tandem HDCT consisting of etoposide, cisplatin, and mitomycin, followed by autologous bone marrow...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Combined Chemotherapy Protocols
Share to Bone Marrow Transplantation

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Chemotherapy, Adjuvant

Share to Genes, p53

Share to Neoplasm Metastasis

Share to Preoperative Care

Share to Stomach Neoplasms

Share to Survival Analysis

Source

Open in PubMed Open full text

Identifiers

PMID: 14514923
DOI: 10.1136/mp.56.5.286
PMCID: PMC1187340

Genes

BAX
APC

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Alterations in p53 predict response to preoperative high dose chemotherapy in patients with gastric cancer.PMID 14514923Read ↗

Chromosomal instability rather than p53 mutation is associated with response to neoadjuvant cisplatin-based chemotherapy in gastric carcinoma.Semantic proximity Read ↗

Allelic imbalance at p53 and microsatellite instability are predictive markers for resistance to chemotherapy in gastric carcinoma.Semantic proximity Read ↗

Epidermal growth factor receptor, p53 mutation, and pathological response predict survival in patients with locally advanced esophageal cancer treated with preoperative chemoradiotherapy.Semantic proximity Read ↗

p53 sequence analysis predicts treatment response and outcome of patients with esophageal carcinoma.Semantic proximity Read ↗

Loss of heterozygosity and microsatellite instability as predictive markers for neoadjuvant treatment in gastric carcinoma.Semantic proximity Read ↗

CyclinD1 and interleukin-1 receptor antagonist polymorphisms are associated with prognosis in neoadjuvant-treated gastric carcinoma.Semantic proximity Read ↗

Relationship between p53 status and response to chemotherapy in patients with gastric cancer: a meta-analysis.Semantic proximity Read ↗

The p53 gene is a potent determinant of chemosensitivity and radiosensitivity in gastric and colorectal cancers.Semantic proximity Read ↗

p53 Mutation status predicts pathological response to chemoradiotherapy in locally advanced esophageal cancer.Semantic proximity Read ↗

The biomarker TP53 divides patients with neoadjuvantly treated esophageal cancer into 2 subgroups with markedly different outcomes. A p53 Research Group study.Semantic proximity Read ↗

Combined p53/Bax mutation results in extremely poor prognosis in gastric carcinoma with low microsatellite instability.Semantic proximity Read ↗

p53 accumulation and mutation are prognostic indicators of poor survival in human gastric carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.